Thway, K., Harrington, K. J., Melcher, A. A., Crespo-Rodriguez, E., Bergerhoff, K., Bozhanova, G., . . . Pedersen, M. Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationThway, Khin, et al. Combining BRAF Inhibition with Oncolytic Herpes Simplex Virus Enhances the Immune-mediated Antitumor Therapy of BRAF-mutant Thyroid Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationThway, Khin, et al. Combining BRAF Inhibition with Oncolytic Herpes Simplex Virus Enhances the Immune-mediated Antitumor Therapy of BRAF-mutant Thyroid Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.